What the study found
Roughly half of people with sputum trace ultra results were recommended tuberculosis therapy.
Why the authors say this matters
The authors say this prevalence supports treating most people with sputum trace ultra results when multimodal testing and repeated clinical evaluations are not feasible. They also suggest that some people with low-risk characteristics and negative results on other commonly available diagnostic tests could safely defer treatment with clinical follow-up.
What the researchers tested
The abstract describes a study of adults and adolescents with sputum trace ultra results in two high-burden clinical settings. It appears to have examined prevalence of tuberculosis and predictors associated with those results, but the abstract does not provide detailed methods beyond that.
What worked and what didn't
The main result reported is that about half of these patients were recommended tuberculosis therapy. The authors also report low observed mortality and say that some lower-risk patients with negative results on other widely available diagnostic tests might defer treatment with follow-up.
What to keep in mind
The available summary is brief and does not describe detailed methods, specific predictors, or exact outcome numbers beyond the approximate treatment recommendation rate and low observed mortality. The conclusions are limited to the settings described in the abstract.
Key points
- About half of adults and adolescents with sputum trace ultra results were recommended tuberculosis therapy.
- The authors say this supports treating most such patients when repeated testing and clinical reassessment are not feasible.
- Some people with low-risk characteristics and negative results on other widely available diagnostic tests may be able to defer treatment with follow-up, according to the authors.
- The abstract reports low observed mortality.
- The study was set in two high-burden clinical settings.
Disclosure
- Research title:
- About half with trace ultra results were recommended tuberculosis therapy
- Authors:
- Caitlin Visek, Ronit R. Dalmat, Annet Nalutaaya, Kamoga Caleb Erisa, Patrick Biché, Gordon Stein, Amanda Ganguloo, R. P. Draper, Mariam Nantale, Adrienne E. Shapiro, D. Wilson, Achilles Katamba, Paul K Drain, Emily A. Kendall
- Institutions:
- Johns Hopkins University, Johns Hopkins Medicine, University of Washington, Novosibirsk Tuberculosis Research Institute, Edendale Hospital, Grey's Hospital, Umkhuseli Innovation and Research Management, Makerere University
- Publication date:
- 2026-03-20
- OpenAlex record:
- View
Get the weekly research newsletter
Stay current with peer-reviewed research without reading academic papers — one filtered digest, every Friday.


